Operating profit before deduction of amortization: Theratechnologies (THTX)
The automation of HIV drug synthesis accelerates development but requires expert involvement. The consolidated EBITDA reflects cash flow volatility, with the current level sitting around . Patent protection and stringent FDA oversight create barriers to entry for competitors, while the digitalization of distribution monitoring via contract platforms optimizes logistics for Theratechnologies Inc. (THTX).
Theratechnologies (THTX) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Theratechnologies Inc.|THTX - Long-Term Debt to Capital|Current Liabilities to Capital Theratechnologies, Inc.|THTX - Company Total Debt|Debt to Book Capital Theratechnologies|THTX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Theratechnologies|Immediate Liquidity theratech.com
- earnings and multiples data:
THTX - Company Net Income|Expected Net Income Theratechnologies Inc.|THTX - P/E Multiple|Forward P/E Multiple theratech.com|THTX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Theratechnologies|THTX - Operating profit EBITDA|Net earnings per one share for the last twelve months Theratechnologies|THTX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months theratech.com|THTX - Earnings growth in current year|Expected earnings per share trend next year Theratechnologies Inc.
Fundamental company valuation:Theratechnologies, Inc THTX
This indicator measures net cash flow from operating activities before depreciation and interest, determining the business's fundamental ability to generate liquidity for scaling. Analysis of the EBITDA_Co chart on the GURU.Markets platform allows for an assessment of the financial stability of Theratechnologies Inc. (THTX), whose profits are supported by high margins on orphan drugs for HIV patients and protection against competitive pricing pressure.
Who Theratechnologies Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX: Operating profit before deduction of amortization|Vera Corp - Company profit before taxes, interest and amortization|DNTH: Operating profit EBITDA|pharvaris.com - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating profit EBITDA upstreambio.com UPB|ZBIO: Operating profit before deduction of amortization|Immunome Inc - Company profit before taxes, interest and amortization|GOSS: Operating profit EBITDA|Profit before interest, taxes and amortization KalVista Corp (KALV)|SEPN (Septerna Inc) - Operating profit EBITDA|Operating profit before deduction of amortization pieris.com (PVLA)|Operating profit EBITDA SVRA|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization AnaptysBio Corp ANAB|ATXS: Operating profit before amortization|ENGN - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|ACRS (Aclaris Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Kyverna|Profit before interest, taxes and amortization Tiziana Life Sciences, Ltd. TLSA|Operating profit EBITDA CABA|ventyxbio.com (VTYX) - Operating profit before depreciation charges|Operating profit EBITDA AVTX (Avalo Therapeutics)|Operating income before deduction of amortization Eledon Pharmaceuticals Inc. (ELDN)|Agenus Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Climb Bio, Inc|Zura Bio (ZURA) - Profit before payment of interest, taxes and amortization|ATYR - Operating income before deduction of amortization|Operating profit before deduction of amortization ADAG|IMA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA STTK|Operating income before deduction of amortization equilliumbio.com|Profit before payment of interest, taxes and amortization Connect Biopharma Holdings Limited CNTB|IMUX: Operating profit before amortization|Atara Biotherapeutics Inc - Operating profit EBITDA|InflaRx N.V. (IFRX) - Operating profit before deduction of amortization|XFOR (X4 Pharma) - Operating profit before deduction of amortization|ACET - Operating income before deduction of amortization|Operating profit before deduction of amortization CELU|INMB (inmunebio.com) - Company profit before taxes, interest and amortization|Operating profit EBITDA BRNS|KZR (Kezar Life Sciences Inc.) - Income before deduction of interest, taxes and amortization|SAB Biotherapeutics, Inc - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization AKTX (Akari Therapeutics, Plc)|ENLV: Operating profit before deduction of amortization|QTTB (Q32 Bio Inc.) - Operating profit before amortization|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization EDSA (Edesa Biotech Inc)|IBIO (iBio Corp) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit EBITDA boltbio.com (BOLT)|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|Income before deduction of interest, taxes and amortization APVO|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI: Operating profit EBITDA|xortx.com (XRTX) - Operating profit EBITDA|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating income before deduction of amortization BiondVax Pharmaceuticals|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK - Profit before payment of interest, taxes and amortization|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS (igmbio.com) - Operating profit before deduction of amortization|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit EBITDA THRD
